Neotrace-4
FDA Approves Dotarem, a New MRI Agent »
"The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older.
Dotarem is a gadolinium-based"...
Neotrace-4
DRUG DESCRIPTION
Neotrace®-4 is a sterile, nonpyrogenic solution of four trace elements for use as an additive for total parenteral nutrition (TPN).
Each mL contains:
| Zinc Sulfate heptahydrate (equivalent to Zinc 1.5 mg) | 6.6 mg |
| Cupric Sulfate pentahydrate (equivalent to Copper 0.1 mg) | 0.39 mg |
| Manganese Sulfate monohydrate (equivalent to Manganese 25 mcg) | 77 mcg |
| Chromic Chloride hexahydrate (equivalent to Chromium 0.85 mcg) | 4.36 mcg |
| Water for Injection, USP | q. s. |
Zinc Sulfate is chemically designated ZnSO4, a white crystalline compound freely soluble in water.
Cupric Sulfate is chemically designated CuSO4, a blue crystalline compound very soluble in water.
Manganese Sulfate is chemically designated MnSO4, a pale red, slightly efflorescent compound soluble in water.
Chromic Chloride is chemically designated CrCl3, a greenish compound, soluble in water.
pH (approximately 2.5) adjusted with sulfuric acid.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Neotrace-4 Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
